Dynamic Drug Advancement Limited

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis4 trials

Phase

• Phase 34 trials

Status

• Recruiting2 trials
• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• United Therapeutics3 trials
• PureTech1 trial

Running trials

• Recruiting

  Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  NCT07284602· Phase 3· PureTech· Source

  Contact: George Philteos, MD

• Recruiting

  Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  NCT05943535· Phase 3· United Therapeutics· Source

  Contact: Cynthia Lee

• Enrolling by invitation

  Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

  NCT04905693· Phase 3· United Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Idiopathic pulmonary fibrosis3 recruiting

Closed trials

• Completed

  Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT04708782· Phase 3· United Therapeutics· Source